Morgan Stanley’s Hinge Health HNGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$134M Buy
1,613,901
+624,312
+63% +$33.9M 0.01% 1326
2026
Q1
$38.2M Buy
989,589
+231,808
+31% +$9.63M ﹤0.01% 2370
2025
Q4
$35.2M Buy
757,781
+553,412
+271% +$26.7M ﹤0.01% 2419
2025
Q3
$10M Buy
204,369
+101,592
+99% +$5.31M ﹤0.01% 3549
2025
Q2
$5.32M Buy
+102,777
New +$4.15M ﹤0.01% 4016

Other funds holding HNGE

Morgan Stanley's HNGE Position: Q2 2026 in Review

Morgan Stanley increased its Hinge Health (HNGE) stake by 63% in Q2 2026, buying an estimated $33.9M and bringing the position to 1,613,901 shares worth $134M. The position accounts for 0.01% of the portfolio, ranked #1326.

Morgan Stanley first reported a position in HNGE in Q2 2025 and has held it in 5 quarters since. 277 funds tracked by Wall St. Rank hold HNGE as of Q2 2026.

  • Morgan Stanley held 1,613,901 shares of Hinge Health worth $134M as of Q2 2026.
  • Morgan Stanley bought 624,312 Hinge Health shares in Q2 2026, an estimated $33.9M.
  • Hinge Health made up 0.01% of Morgan Stanley's portfolio in Q2 2026, its #1326 holding.
  • Morgan Stanley first reported a position in Hinge Health in Q2 2025 and has held it in 5 quarters since.
  • 277 funds tracked by Wall St. Rank held Hinge Health as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.